SD
Stephanie Davis Barclays Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Quest Diagnostics
DGX
$20.4B
| $182.53 | $185 |
1%
upside
| Equal-Weight |
23 Apr ‘25
4 months ago |
|
|
WAY
2
Waystar Holding Corp
WAY
$7.12B
| $40.86 | $45 |
10%
upside
| Overweight |
14 Apr ‘25
4 months ago |
|
3
OptimizeRx
OPRX
$340M
| $18.29 | $5 |
73%
downside
| Equal-Weight |
14 Nov ‘24
9 months ago |
|
4
Doximity
DOCS
$13B
| $69.52 | $75 |
8%
upside
| Overweight |
11 Nov ‘24
10 months ago |
|
5
Lifestance Health
LFST
$2.18B
| $5.61 | $7 |
25%
upside
| Underweight |
11 Nov ‘24
10 months ago |
|
6
GoodRx Holdings
GDRX
$1.43B
| $4.12 | $6 |
46%
upside
| Overweight |
11 Nov ‘24
10 months ago |
|
7
Evolent Health
EVH
$1.12B
| $9.67 | $19 |
96%
upside
| Overweight |
11 Nov ‘24
10 months ago |
|
8
Cencora
COR
$57.7B
| $297.86 | $290 |
3%
downside
| Overweight |
7 Nov ‘24
10 months ago |
|
9
Premier
PINC
$2.24B
| $27.11 | $24 |
11%
downside
| Equal-Weight |
6 Nov ‘24
10 months ago |
|
10
Cardinal Health
CAH
$35.9B
| $150.28 | $133 |
12%
downside
| Overweight |
4 Nov ‘24
10 months ago |
|
11
Omnicell
OMCL
$1.49B
| $32.33 | $58 |
79%
upside
| Equal-Weight |
31 Oct ‘24
10 months ago |
|
12
Talkspace
TALK
$447M
| $2.67 | $3 |
12%
upside
| Equal-Weight |
29 Oct ‘24
10 months ago |
|
13
Labcorp
LH
$23B
| $277.21 | $249 |
10%
downside
| Equal-Weight |
2 Aug ‘24
1 year ago |
|
14
TruBridge
TBRG
$300M
| $19.96 | $10 |
50%
downside
| Equal-Weight |
22 Jan ‘24
1 year ago |
|
15
Phreesia
PHR
$1.6B
| $26.78 | $29 |
8%
upside
| Overweight |
3 Jan ‘24
1 year ago |
|
16
Teladoc Health
TDOC
$1.39B
| $7.84 | $34 |
334%
upside
| Outperform |
23 Feb ‘23
2 years ago |
|
|
17
Premier
PINC
$2.24B
| $27.11 | $42 |
55%
upside
| Outperform |
8 Feb ‘23
2 years ago |
|
|
18
Phreesia
PHR
$1.6B
| $26.78 | $39 |
46%
upside
| Outperform |
5 Jan ‘23
2 years ago |
|
19
Progyny
PGNY
$1.96B
| $22.85 | $34 |
49%
upside
| Market Perform |
5 Jan ‘23
2 years ago |
|
20
Veeva Systems
VEEV
$46.3B
| $282.78 | $233 |
18%
downside
| Outperform |
2 Dec ‘22
2 years ago |
|
21
Health Catalyst
HCAT
$238M
| $3.38 | $17 |
403%
upside
| Outperform |
9 Nov ‘22
2 years ago |
|
|
22
Talkspace
TALK
$447M
| $2.67 | $1 |
63%
downside
| Market Perform |
9 Nov ‘22
2 years ago |
|
|
23
GoodRx Holdings
GDRX
$1.43B
| $4.12 | $11 |
167%
upside
| Market Perform |
9 Aug ‘22
3 years ago |
|
24
HealthEquity
HQY
$8.02B
| $93.06 | $76 |
18%
downside
| Outperform |
7 Jun ‘22
3 years ago |
|
|
25
Doximity
DOCS
$13B
| $69.52 | $67 |
4%
downside
| Outperform |
18 May ‘22
3 years ago |
|